Talk to a certified wellness coach free — a real 15-minute call, no cost, no card. Book your free call
OS Reboot
See if you qualify

Foundayo at a glance

An FDA-approved brand medication, available only when a licensed physician determines it is appropriate for you. Nothing is prescribed unless a licensed physician determines it is appropriate for you.

Protocol
Foundayo
Category
Branded GLP-1
Medicine type
Oral tablet
Availability
Prescription only. An FDA-approved medication, supplied only where a licensed physician determines it is appropriate after an individual evaluation.
Dispensed by
A U.S. state-licensed pharmacy.

About Foundayo

What it is

Orforglipron, a once-daily oral GLP-1 receptor agonist. It is a small molecule rather than a peptide, which is why it can be taken as a tablet instead of injected. FDA-approved for chronic weight management in April 2026.

How it is used

Taken by mouth daily, prescribed only where a physician finds it appropriate for you, alongside a reduced-calorie diet and increased physical activity.

What to discuss with your physician

Share any history of pancreatitis, gallbladder disease, kidney problems, or thyroid or endocrine tumours, plus every other medicine you take. Ask what to do about a missed day, since this one is daily rather than weekly.

Educational information only. It is not medical advice and does not describe results you should expect. A licensed physician decides what, if anything, is appropriate for you.

Foundayo, explained

What Foundayo is

Foundayo is the brand name for orforglipron, a small-molecule GLP-1 receptor agonist — not a peptide — which is what makes it possible to take as a simple once-daily oral tablet, with no injections and no refrigeration. It is FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition, as an adjunct to a reduced-calorie diet and increased physical activity.

What its clinical trial showed

In ATTAIN-1, the pivotal 72-week trial, adults taking the highest studied dose of orforglipron alongside a reduced-calorie diet and increased physical activity saw an average total body-weight reduction of 12.4%. It is a trial average, not a prediction of your result. Individual results vary, not everyone qualifies, and no outcome is guaranteed.

How you get it

You complete a private online evaluation, and a state-licensed physician in the affiliated medical network reviews your health history. Foundayo is prescription-only: it is prescribed only if that physician determines it is appropriate for you, and you are charged for medication only after a prescription is issued. If prescribed, it ships from a U.S. state-licensed pharmacy.

Common questions

Is Foundayo FDA-approved?
Yes. Foundayo (orforglipron) is FDA-approved for chronic weight management, as an adjunct to a reduced-calorie diet and increased physical activity.
Is it really a tablet, not an injection?
Yes — orforglipron is a small molecule rather than a peptide, so it is taken as a once-daily oral tablet.
Do I need a prescription?
Yes. A licensed physician reviews your evaluation and prescribes only if it is appropriate for you — not everyone qualifies.

Educational information only — not medical advice, a diagnosis, or a prescription, and no outcomes or weight-loss guarantees are made or implied. Every medical decision is made by a licensed physician based on your individual history. Medications carry risks and side effects — see the important safety information on this page. Not everyone qualifies.

osrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosreboot